Literature DB >> 25865815

Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection.

Atul F Kamath1, Kevin L Ong2, Edmund Lau3, Vanessa Chan4, Thomas P Vail5, Harry E Rubash6, Daniel J Berry7, Kevin J Bozic4.   

Abstract

Periprosthetic joint infection (PJI) represents substantial clinical and economic burdens. This study evaluated patient and procedure characteristics and resource utilization associated with revision arthroplasty for PJI. The Nationwide Inpatient Sample (Q4 2005-2010) was analyzed for 235,857 revision THA (RTHA) and 301,718 revision TKA (RTKA) procedures. PJI was the most common indication for RTKA, and the third most common reason for RTHA. PJI was most commonly associated with major severity of illness (SOI) in RTHA, and with moderate SOI in RTKA. RTHA and RTKA for PJI had the longest length of stay. Costs were higher for RTHA/RTKA for PJI than for any other diagnosis except periprosthetic fracture. Epidemiologic differences exist in the rank, severity and populations for RTHA and RTKA for PJI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  epidemiology; infection; revision arthroplasty; total hip arthroplasty (replacement); total knee arthroplasty

Mesh:

Year:  2015        PMID: 25865815     DOI: 10.1016/j.arth.2015.03.035

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  59 in total

1.  CORR Insights®: What Are the Frequency, Associated Factors, and Mortality of Amputation and Arthrodesis After a Failed Infected TKA?

Authors:  Jacob M Drew
Journal:  Clin Orthop Relat Res       Date:  2017-03-17       Impact factor: 4.176

2.  Periarticular joint infection: Survey of the European Knee Associates (EKA) of ESSKA.

Authors:  Antonia F Chen; Sufian S Ahmad; Michael T Hirschmann; Sandro Kohl; Olivier Borens; Roland Becker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10       Impact factor: 4.342

Review 3.  The Role of One-Stage Exchange for Prosthetic Joint Infection.

Authors:  Fiachra E Rowan; Matthew J Donaldson; Jurek R Pietrzak; Fares S Haddad
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 4.  The Use of Antibiograms in Orthopedic Surgery.

Authors:  Scott R Nodzo; Nicholas B Frisch
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

5.  Superficial wound infection does not cause inferior clinical outcome after TKA.

Authors:  Pau Guirro; Pedro Hinarejos; Lluís Puig-Verdie; Juan Sánchez-Soler; Joan Leal-Blanquet; Raul Torres-Claramunt; Joan-Carles Monllau
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-08-27       Impact factor: 4.342

Review 6.  Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies.

Authors:  Mitchell C Birt; David W Anderson; E Bruce Toby; Jinxi Wang
Journal:  J Orthop       Date:  2016-10-26

7.  Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: An in vitro study.

Authors:  James X Liu; Dalibel Bravo; John Buza; Thorsten Kirsch; Oran Kennedy; Andrew Rokito; Joseph D Zuckerman; Mandeep S Virk
Journal:  J Orthop       Date:  2018-01-30

8.  Integrated clinical pathways with watertight, multi-layer closure to improve patient outcomes in total hip and knee joint arthroplasty.

Authors:  Mark A Snyder; Alexandra N Sympson; Steven J Wurzelbacher; Po-Han Brian Chen; Frank R Ernst
Journal:  J Orthop       Date:  2019-09-19

9.  The economic impact of periprosthetic infection in total hip arthroplasty

Authors:  Jason Akindolire; Mina W. Morcos; Jacquelyn D. Marsh; James L. Howard; Brent A. Lanting; Edward M. Vasarhelyi
Journal:  Can J Surg       Date:  2020-01-29       Impact factor: 2.089

10.  Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant-associated bone infection.

Authors:  Christopher W Farnsworth; Eric M Schott; Abigail M Benvie; Jacob Zukoski; Stephen L Kates; Edward M Schwarz; Steven R Gill; Michael J Zuscik; Robert A Mooney
Journal:  J Orthop Res       Date:  2018-01-03       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.